BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 1658622)

  • 21. Folate receptors as potential therapeutic targets in choroid plexus tumors of SV40 transgenic mice.
    Patrick TA; Kranz DM; van Dyke TA; Roy EJ
    J Neurooncol; 1997 Apr; 32(2):111-23. PubMed ID: 9120540
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of the genetic background of transgenic mice upon the formation and timing of choroid plexus papillomas.
    Cho HJ; Seiberg M; Georgoff I; Teresky AK; Marks JR; Levine AJ
    J Neurosci Res; 1989 Sep; 24(1):115-22. PubMed ID: 2478718
    [TBL] [Abstract][Full Text] [Related]  

  • 23. JC virus and simian virus 40 enhancers and transforming proteins: role in determining tissue specificity and pathogenicity in transgenic mice.
    Feigenbaum L; Hinrichs SH; Jay G
    J Virol; 1992 Feb; 66(2):1176-82. PubMed ID: 1309896
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationship between simian virus 40 large tumor antigen expression and tumor formation in transgenic mice.
    Van Dyke TA; Finlay C; Miller D; Marks J; Lozano G; Levine AJ
    J Virol; 1987 Jun; 61(6):2029-32. PubMed ID: 3033329
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of a transgenic mouse system for the analysis of stages in liver carcinogenesis using tissue-specific expression of SV40 large T-antigen controlled by regulatory elements of the human alpha-1-antitrypsin gene.
    Sepulveda AR; Finegold MJ; Smith B; Slagle BL; DeMayo JL; Shen RF; Woo SL; Butel JS
    Cancer Res; 1989 Nov; 49(21):6108-17. PubMed ID: 2551499
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Requirements for species-specific papovavirus DNA replication.
    Bennett ER; Naujokas M; Hassell JA
    J Virol; 1989 Dec; 63(12):5371-85. PubMed ID: 2555562
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Localization of common cytotoxic T lymphocyte recognition epitopes on simian papovavirus SV40 and human papovavirus JC virus T antigens.
    Deckhut AM; Tevethia MJ; Haggerty S; Frisque RJ; Tevethia SS
    Virology; 1991 Jul; 183(1):122-32. PubMed ID: 1711255
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Requirement for the simian virus 40 small tumor antigen in tumorigenesis in transgenic mice.
    Choi YW; Lee IC; Ross SR
    Mol Cell Biol; 1988 Aug; 8(8):3382-90. PubMed ID: 2850490
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transactivation of BKV and SV40 early promoters by BKV and SV40 T-antigens.
    Caputo A; Barbanti-Brodano G; Wang E; Ricciardi RP
    Virology; 1986 Jul; 152(2):459-65. PubMed ID: 3014726
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oncogenes: growth regulation and the papovaviruses polyoma and SV40.
    Smith AE
    J Cell Biochem; 1984; 26(2):89-93. PubMed ID: 6098586
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Studies of human papovavirus tumor antigen in experimental and human cerebral neoplasms.
    Becker LE; Narayan O; Johnson RT
    Can J Neurol Sci; 1976 May; 3(2):105-9. PubMed ID: 178420
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SV40 T antigen transgenic mice: cytotoxic T lymphocytes as a selective force in tumor progression.
    Knowles BB; Faas S; Juretic A; Fox N; Crooke R; Hanahan D; Solter D; Jewett L
    Basic Life Sci; 1991; 57():111-24; discussion 125. PubMed ID: 1726037
    [No Abstract]   [Full Text] [Related]  

  • 33. Monoclonal antibody specific for BK virus large-T antigen allows discrimination among the different papovaviral large-T antigens.
    Marshall J; Smith AE; Cheng SH
    Oncogene; 1991 Sep; 6(9):1673-6. PubMed ID: 1656370
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Induction of tumors in Syrian hamsters by a human renal papovavirus, RF strain.
    Dougherty RM
    J Natl Cancer Inst; 1976 Aug; 57(2):395-400. PubMed ID: 63561
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of viral T-antigen in pathological tissues from transgenic mice carrying JC-SV40 chimeric DNAs.
    Ressetar HG; Prakash O; Frisque RJ; Webster HD; Re RN; Stoner GL
    Mol Chem Neuropathol; 1993 Sep; 20(1):59-79. PubMed ID: 8251033
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Isolation of a papovavirus with a bipartite genome containing unlinked SV40 and BKV sequences.
    O'Neill FJ; Miller TH
    Virology; 1985 May; 143(1):75-87. PubMed ID: 2998014
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The SV40 "S" antigen and other papovavirus-induced surface antigens.
    Collins JJ; Black PH
    Curr Top Microbiol Immunol; 1974; 63():153-83. PubMed ID: 4364182
    [No Abstract]   [Full Text] [Related]  

  • 38. Antibody response to human papovavirus JC (JCV) and simian virus 40 (SV40) T antigens in SV40 T antigen-transgenic mice.
    Tevethia SS; Epler M; Georgoff I; Teresky A; Marlow M; Levine AJ
    Virology; 1992 Sep; 190(1):459-64. PubMed ID: 1382342
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Control of advanced choroid plexus tumors in SV40 T antigen transgenic mice following priming of donor CD8(+) T lymphocytes by the endogenous tumor antigen.
    Schell TD; Tevethia SS
    J Immunol; 2001 Dec; 167(12):6947-56. PubMed ID: 11739514
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Monoclonal antibodies against simian virus 40 nuclear large T tumour antigen: epitope mapping, papova virus cross-reaction and cell surface staining.
    Ball RK; Siegl B; Quellhorst S; Brandner G; Braun DG
    EMBO J; 1984 Jul; 3(7):1485-91. PubMed ID: 6204863
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.